Menu Search
Equities

BRAIN Biotech AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert
0RFI:LSE

BRAIN Biotech AG

Actions
  • Price (EUR)2.27
  • Today's Change0.00 / 0.00%
  • Shares traded56.00
  • 1 Year change-26.30%
  • Beta0.7389
Data delayed at least 20 minutes, as of Feb 06 2026 10:29 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.

  • Revenue in EUR (TTM)50.22m
  • Net income in EUR-11.74m
  • Incorporated2000
  • Employees281.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.